Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Jade Biosciences, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 60
- −6 vs. Q1 2023
- Shares held
- 28.5M
- +2.49M (+9.6%) vs. Q1 2023
- Total value
- $488.3M
- −$35.8M (−6.8%) vs. Q1 2023
- New holders
- 3
- 24 more added
- Sold out
- 9
- 13 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,263,982 | $141.7M | 2.68% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,758,686 | $64.5M | 4.26% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 2,201,274 | $37.8M | 6.19% | +1,120,000+103.6% | Added |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $35.0M | 4.35% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,963,479 | $33.7M | 0.19% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,561,696 | $26.8M | 1.53% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 1,194,091 | $20.5M | 0.26% | +1,194,091 | New |
| Frazier Life Sciences Management, L.P. | 994,858 | $17.1M | 1.02% | +656,748+194.2% | Added |
| Great Point Partners LLC | 932,158 | $16.0M | 3.20% | +176,538+23.4% | Added |
| OrbiMed Advisors LLC | 756,930 | $13.0M | 0.25% | 00.0% | Unchanged |
| FMR LLC | 727,614 | $12.5M | 0.00% | +156,649+27.4% | Added |
| BlackRock Inc. | 622,647 | $10.7M | 0.00% | +22,648+3.8% | Added |
| Octagon Capital Advisors LP | 621,712 | $10.7M | 1.49% | 00.0% | Unchanged |
| OUP Management Co., LLC | 603,762 | $10.4M | 17.66% | 00.0% | Unchanged |
| Vanguard Group Inc | 523,567 | $8.98M | 0.00% | +10,255+2.0% | Added |
| Citadel Advisors LLC | 291,938 | $5.01M | 0.01% | +291,938 | New |
| Geode Capital Management, LLC | 203,058 | $3.48M | 0.00% | +15,559+8.3% | Added |
| Ghost Tree Capital, LLC | 201,197 | $3.45M | 1.25% | +1,197+0.6% | Added |
| State Street Corp | 188,874 | $3.24M | 0.00% | +4,281+2.3% | Added |
| Nantahala Capital Management, LLC | 95,000 | $1.63M | 0.20% | 00.0% | Unchanged |
| Northern Trust Corp | 87,997 | $1.51M | 0.00% | +10,558+13.6% | Added |
| Fred Alger Management, LLC | 57,874 | $992.5K | 0.01% | −46,174−44.4% | Reduced |
| Skandinaviska Enskilda Banken AB (publ) | 50,866 | $872.0K | 0.01% | 00.0% | Unchanged |
| Eversept Partners, LP | 50,242 | $861.6K | 0.09% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 47,936 | $822.1K | 0.53% | 00.0% | Unchanged |
| HighVista Strategies LLC | 41,803 | $716.9K | 0.33% | +25,970+164.0% | Added |
| Nuveen Asset Management, LLC | 36,310 | $622.7K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 33,387 | $572.6K | 0.00% | +12,595+60.6% | Added |
| Morgan Stanley | 33,026 | $566.4K | 0.00% | −11,948−26.6% | Reduced |
| Two Sigma Investments, LP | 30,011 | $514.7K | 0.00% | +18,502+160.8% | Added |
| Bank of New York Mellon Corp | 27,232 | $467.0K | 0.00% | −563−2.0% | Reduced |
| Charles Schwab Investment Management Inc | 26,673 | $457.4K | 0.00% | +2,032+8.2% | Added |
| Dimensional Fund Advisors LP | 25,011 | $428.4K | 0.00% | +13,397+115.4% | Added |
| Parkwood LLC | 22,832 | $392.0K | 0.07% | −3,031−11.7% | Reduced |
| Alps Advisors Inc | 18,320 | $314.2K | 0.00% | +2,112+13.0% | Added |
| Swiss National Bank | 16,201 | $277.8K | 0.00% | −2,400−12.9% | Reduced |
| Ensign Peak Advisors, Inc | 15,000 | $257.3K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 12,986 | $222.7K | 0.00% | −1,812−12.2% | Reduced |
| Alliancebernstein L.P. | 11,720 | $201.0K | 0.00% | +11,720 | New |
| Golden State Equity Partners | 10,530 | $180.6K | 0.05% | 00.0% | Unchanged |
| California State Teachers Retirement System | 9,896 | $169.7K | 0.00% | −1,063−9.7% | Reduced |
| JPMorgan Chase & Co | 8,070 | $138.4K | 0.00% | +986+13.9% | Added |
| Bank of America Corp | 6,296 | $108.0K | 0.00% | −7,006−52.7% | Reduced |
| Legal & General Group Plc | 5,774 | $99.0K | 0.00% | +2,343+68.3% | Added |
| MetLife Investment Management | 5,228 | $89.7K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 4,985 | $85.5K | 0.00% | −654−11.6% | Reduced |
| American International Group, Inc. | 4,844 | $83.1K | 0.00% | +412+9.3% | Added |
| New York State Common Retirement Fund | 4,273 | $73.3K | 0.00% | −3,411−44.4% | Reduced |
| Wells Fargo & Company | 4,200 | $72.0K | 0.00% | +2,564+156.7% | Added |
| Barclays PLC | 3,406 | $58.4K | 0.00% | −1,314−27.8% | Reduced |
| Citigroup Inc | 3,324 | $57.0K | 0.00% | +3,095+1,351.5% | Added |
| UBS Group AG | 2,999 | $51.4K | 0.00% | −2,987−49.9% | Reduced |
| STRS Ohio | 2,300 | $39.0K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,535 | $26.0K | 0.00% | +548+55.5% | Added |
| Russell Investments Group, Ltd. | 939 | $16.1K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 908 | $15.6K | 0.00% | −1,794−66.4% | Reduced |
| Royal Bank of Canada | 880 | $15.0K | 0.00% | +365+70.9% | Added |
| Ameritas Investment Partners, Inc. | 772 | $13.2K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 701 | $12.0K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 7 | $120 | 0.00% | +3+75.0% | Added |
| VR Adviser, LLC | 0 | $0 | 0.00% | −833,927−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −195,146−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −69,119−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −39,573−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −17,600−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −15,958−100.0% | Sold out |
| Trustees of Columbia University in the City of New York | 0 | $0 | 0.00% | −13,190−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −202−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |